LifeVantage Co. (NASDAQ:LFVN) Sees Significant Drop in Short Interest

LifeVantage Co. (NASDAQ:LFVN - Get Free Report) was the target of a significant decrease in short interest in May. As of May 15th, there was short interest totalling 1,780,000 shares, a decrease of 12.7% from the April 30th total of 2,040,000 shares. Currently, 17.6% of the company's stock are short sold. Based on an average daily volume of 188,500 shares, the days-to-cover ratio is currently 9.4 days.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in LFVN. Acadian Asset Management LLC grew its holdings in shares of LifeVantage by 47.3% during the first quarter. Acadian Asset Management LLC now owns 291,700 shares of the company's stock worth $4,248,000 after buying an additional 93,661 shares during the last quarter. Jane Street Group LLC grew its holdings in LifeVantage by 5.4% in the first quarter. Jane Street Group LLC now owns 36,567 shares of the company's stock valued at $533,000 after purchasing an additional 1,877 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in LifeVantage by 24.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 44,518 shares of the company's stock valued at $649,000 after acquiring an additional 8,762 shares during the last quarter. Jones Financial Companies Lllp grew its position in shares of LifeVantage by 14,484.0% in the first quarter. Jones Financial Companies Lllp now owns 29,168 shares of the company's stock valued at $425,000 after purchasing an additional 28,968 shares during the last quarter. Finally, Cubist Systematic Strategies LLC purchased a new position in LifeVantage during the first quarter worth $97,000. Hedge funds and other institutional investors own 35.32% of the company's stock.

LifeVantage Stock Performance

Shares of LFVN traded down $0.03 during midday trading on Friday, hitting $12.35. The company had a trading volume of 66,016 shares, compared to its average volume of 144,208. LifeVantage has a 1 year low of $5.22 and a 1 year high of $27.38. The company's 50-day simple moving average is $13.10 and its 200-day simple moving average is $16.20. The firm has a market capitalization of $155.46 million, a P/E ratio of 22.05 and a beta of 0.41.

LifeVantage (NASDAQ:LFVN - Get Free Report) last announced its quarterly earnings results on Tuesday, May 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.16 by $0.10. The company had revenue of $58.44 million during the quarter, compared to the consensus estimate of $60.99 million. LifeVantage had a return on equity of 34.29% and a net margin of 3.46%.

LifeVantage Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 13th. Shareholders of record on Friday, May 30th will be paid a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 1.46%. The ex-dividend date is Friday, May 30th. This is an increase from LifeVantage's previous quarterly dividend of $0.04. LifeVantage's dividend payout ratio is currently 26.09%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.